Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion type Assertion NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_head.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion description "[We speculate that CYP1B1 inhibition in endometrial carcinomas could be a useful therapeutic approach as it regulates several potential anticancer targets like cyclin E1, Skp2, and TRAIL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_provenance.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion evidence source_evidence_literature NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_provenance.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion SIO_000772 19690133 NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_provenance.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion wasDerivedFrom befree-20140225 NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_provenance.
- NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_assertion wasGeneratedBy ECO_0000203 NP717893.RAgvBM_XwW2z7GmC7qllbvzTPb6i-i89LC0HHT6-00kJg130_provenance.